首页 | 本学科首页   官方微博 | 高级检索  
检索        

健脾理气颗粒不同提取工艺对H22肝癌小鼠抑瘤作用的影响
引用本文:吴洪斌,徐立涛,孟志强.健脾理气颗粒不同提取工艺对H22肝癌小鼠抑瘤作用的影响[J].中华中医药杂志,2011(3):591-594.
作者姓名:吴洪斌  徐立涛  孟志强
作者单位:复旦大学附属肿瘤医院复旦大学上海医学院肿瘤学系;
基金项目:上海市科委中药现代化专项基金资助项目(No.06DZ19701)~~
摘    要:目的:探讨健脾理气颗粒5条不同提取工艺路线对H22肝癌小鼠的抑瘤作用,旨在选择最佳提取工艺路线。方法:按5条不同提取工艺路线制备提取物,用蒸馏水配成相应浓度的混悬液;采用细胞接种的方法建立H22肝癌小鼠动物模型,将接种后的小鼠随机分成3组:试验组(按5条不同提取工艺路线分5小组,每小组10例)、空白对照组(15例)和阳性对照组(10例)。检测5条不同提取工艺路线的提取物对H22肝癌小鼠肿瘤抑制的影响。结果:5条不同提取工艺路线提取物的得率分别为工艺路线①35.5%,工艺路线②36.4%,工艺路线③23.5%,工艺路线④31.5%,工艺路线⑤17.9%;对H22肝癌小鼠的抑瘤率分别为工艺路线①22%(P<0.05),工艺路线②31.64%(P<0.01),工艺路线③30.77%(P<0.01),工艺路线④50.32%(P<0.01),工艺路线⑤14.68%;工艺路线②高、中、低剂量组的抑瘤率分别为29.54%(P<0.01),21.43%(P<0.01),4.06%;工艺路线④高、中、低剂量组的抑瘤率分别为41.17%(P<0.01),35.74%(P<0.01),18.23%(P<0.05)。结论:工艺路线④提取物对H22肝癌小鼠的抑瘤率最高,为41.17%-50.32%(P<0.01),由此确定工艺路线④为健脾理气颗粒的最佳提取工艺。

关 键 词:健脾理气颗粒  提取工艺路线  肝癌  抑瘤率

Pharmacodynamics research of anticancer effect of Jianpi Liqi Granules with different extracting techniques in H22 hepatic cancer mice
WU Hong-bin,XU Li-tao,MENG Zhi-qiang.Pharmacodynamics research of anticancer effect of Jianpi Liqi Granules with different extracting techniques in H22 hepatic cancer mice[J].China Journal of Traditional Chinese Medicine and Pharmacy,2011(3):591-594.
Authors:WU Hong-bin  XU Li-tao  MENG Zhi-qiang
Institution:WU Hong-bin,XU Li-tao,MENG Zhi-qiang(Cancer Hospital Affiliated of Fudan University,Department of Medical Oncology,Shanghai Medical College of Fudan Universty,Shanghai 200032,China)
Abstract:Objective: To explore the anticancer effect of Jianpi Liqi Granules with five different extracting techniques in H22 hepatic cancer mice in order to choose the optimal extracting technique.Methods: The Jianpi Liqi Granules were made by five different extracting techniques and injectable suspension was made by mixing the granules with distilled water.After establishing the H22 hepatic cancer mice model by cell vaccination,the cancer-bearing mice were divided into 3 groups: Experimental group with 5 subgroups...
Keywords:Jianpi Liqi Granules  Extracting technique  Liver cancer  Anticancer rate  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号